Stevanato Group S.p.A (STVN) Non-Current Deffered Revenue (2025)
Stevanato Group S.p.A (STVN) reported Non-Current Deffered Revenue of $13.8 million for Q4 2025.
Stevanato Group S.p.A (STVN) Non-Current Deffered Revenue (2025) Analysis & Trends
Stevanato Group S.p.A (STVN) has 1 years of Non-Current Deffered Revenue data on file, last reported at $13.8 million in Q4 2025.
- Non-Current Deffered Revenue for Q4 2025 came in at $13.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $13.8 million (changed N/A YoY), and the FY2025 annual result was $13.8 million, changed N/A from the prior year.
- Non-Current Deffered Revenue was little changed at $13.8 million in Q4 2025 per STVN's latest filing.
- Over five years, Non-Current Deffered Revenue peaked at $13.8 million in Q4 2025 and troughed at $13.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 163.15 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 11.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 208.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.78 Mn |